Comparing two trifocal toric intraocular lenses for cataract surgery.
Official title: A Prospective, Multicenter Clinical Study Comparing Outcomes of Two Trifocal Toric Intraocular Lens
Run by Biotech Healthcare Holding Gmbh · NCT07232615 · Data updated 2026-11-12
This trial will test two different trifocal toric intraocular lenses to see which gives better intermediate-distance vision and satisfaction for adults with cataracts and regular corneal astigmatism.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 138 (estimated) |
| Sponsor | Biotech Healthcare Holding Gmbh Industry-sponsored |
| Locations | 6 sites (Düsseldorf, North Rhine-Westphalia and 5 other locations) |
| Status | Recruiting |
| Started | November 22, 2021 |
| Main results expected | December 2026 |
| Study ends | February 2027 |
| Registry record updated | November 18, 2025 |
| Trial ID | NCT07232615 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 21 with cataract and regular corneal astigmatism between 0.75 and 4.5 D, whose calculated IOL power fits the investigational lenses and who can consent and comply with follow‑up are ideal candidates.
✕Probably not a fit
Patients with prior intraocular or corneal surgery, irregular astigmatism, active ocular disease in the operative eye, certain systemic conditions, pregnancy or lactation, or those outside the specified astigmatism range are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multi‑site interventional comparison enrolls adults having cataract surgery with regular corneal astigmatism who receive one of two commercially available trifocal toric intraocular lenses (Optiflex TRIO or AcrySof IQ PanOptix). The primary outcome is distance‑corrected intermediate visual acuity, with secondary outcomes including safety measures and patient‑reported satisfaction. Eyes will be evaluated preoperatively and at scheduled postoperative visits to measure visual acuity, refractive outcomes, and adverse events. The trial is conducted at three ophthalmology centers in North Rhine‑Westphalia, Germany.
Why it matters
Potential benefit: If successful, the results could help patients achieve better intermediate and overall vision after cataract surgery and reduce dependence on glasses.
How similar studies have gone: Similar trifocal and toric trifocal lenses, including AcrySof PanOptix variations, have shown improved spectacle independence and good visual outcomes in prior published studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age of patient \>21 Years 2. Patient diagnosed with cataract. 3. Patient must have preoperative regular corneal astigmatism between 0.75 to 4.5 D as per corneal topography or keratometry 4. Calculated IOL power is within the range of investigational IOLs. 5. Patient willing to sign inform consent form. 6. Clear intraocular media other than cataract. 7. Female participants of childbearing potential must be willing to ensure that they use effective contraception during the study. Exclusion Criteria: 1. Previous intraocular or corneal surgery. 2. Traumatic cataract 3. Pregnancy (as stated by patient) or lactation. 4. Concurrent participation in another drug or device investigation. 5. Irregular astigmatism. 6. Patient receiving chlorquine treatment. 7. Subjects with any systemic disease that could increase operative risk or confound the outcome. 8. Active ocular disease in the operative eye other than cataract. 9. Vulnerable subjects as defined in section 12.3.9. 10. Corneal Astigmatism \> 4.5 D
Where it's running
-
Internationale Innovative Ophthalmochirurgie GbR
Düsseldorf, North Rhine-Westphalia, Germany Recruiting -
Augentagesklinik
Greven, North Rhine-Westphalia, Germany Recruiting -
Augentagesklinik
Rheine, North Rhine-Westphalia, Germany Recruiting -
Dr. Agarwal Eye Hospital
Chennai, Tamil Nadu, India Recruiting -
Hospital Arruzafa
Córdoba, Córdoba, Spain Recruiting -
Netradhama Superspeciality Eye Hospital
Bangalore, Karnatak, India Not yet recruiting
Study contacts
- Study coordinator: BHARGAV D JOSHI, M.Sc.
- Email: bhargav.joshi@biotechhealthcare.com
- Phone: +917966823000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Corneal Biomechanics and Surgical Astigmatism after Cataract Surgery in Pseudoexfoliation
This study tests how the cornea's biomechanical properties before cataract surgery relate to the amount of blinking surgically induced astigmatism, comparing people with pseudoexfoliation to those without.
-
Rotational Stability of the Acunex Vario Toric
This study tests whether the Acunex Vario toric extended-depth-of-focus intraocular lens stays stable in rotation and effectively reduces astigmatism for people undergoing cataract surgery.
-
Anterior segment anatomy assessment with swept-source OCT in eye surgery patients
This study tests whether swept-source OCT can detail front-eye anatomy in patients undergoing anterior segment eye surgery.
-
MiLOOP-assisted cataract surgery for dense cataracts
In people with dense cataracts, this study tests whether using the miLOOP device during cataract surgery can protect corneal cells and reduce ultrasound energy, compared with standard surgery.
-
Two monthly silicone hydrogel multifocal toric contact lenses in wearers with astigmatism and myopia
This study tests whether two popular soft multifocal toric contact lenses perform differently in adults who need vision correction for astigmatism and myopia.
-
Seeing clearly in low light after Ray-Tracing guided LASIK
A trial tests how well WaveLight Plus LASIK works for people with myopia and astigmatism and whether patients are satisfied after the procedure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.